Rosenberg, Paul B., M.D.

Associate Professor Associate Director, Memory and Alzheimer's Treatment Center Division of Geriatric Psychiatry and Neuropsychiatry Main Office Address Johns Hopkins Bayview Medical Center 5300 Alpha Commons Drive, AC4 Baltimore, MD 21224 Phone: (410) 550-9883 Fax: (410) 550-1407 E-mail: prosenb9@jhmi.edu

Education

Professional Interests

Research:

• preclinical biomarkers of Alzheimer’s disease, including PET and peripheral blood studies of inflammation
• depression and other neuropsychiatric symptoms in Alzheimer’s disease
• clinical trials of new treatments for Alzheimer’s disease

Dr. Rosenberg is a 2008 Paul Beeson Award Scholar, receiving a K08 training grant for the study of PET markers of neuroinflammation in Alzheimer’s Disease.

Selected Publications

Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG.  The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer’s Disease.  Am J Geriatric Psychiatry 2012 (in press).

Rosenberg PB, Mielke MME, Han D, Leoutsakos JS, Lyketsos CG,Rabins PV, Zandi PP, Breitner JCS, Norton MC, Welsh-Bohmer KA, Zuckerman IH, Rattinger GB, Green RC, Corcoran D, Tschanz JT.  The association of psychotropic medication use with the cognitive, functional and neuropsychiatric trajectory of Alzheimer’s disease.  Int J Geriatric Psychiatry 2012 (in press)

Rosenberg PB, Wong DF, Edell S, Ross J, Joshi AD^, Brašić JR, Zhou Y, Raymont V, Kumar A, Ravert HT, Dannals RF, Pontecorvo MJ, Skovronsky DM, Lyketsos CG. Cognition and amyloid load in Alzheimer’s imaged with florbetapir F 18 (AV-45) PET. American Journal of Geriatric Psychiatry 2011 (in press).

Rosenberg PB, Mielke MM, Appleby B, Oh E, Leoutsakos J-M, Lyketsos CG.  Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatric Psychiatry 2010 (in press)

Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos, CG, for the DIADS-2 Research Group. Sertraline for the treatment of depression in Alzheimer’s disease. American Journal of Geriatric Psychiatry 2010; 18:136-45 NIHMS166961